John Drayton Wise

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Bridgewater, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ John Militello, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John Drayton Wise

Form 4 holding Chief Commercial Officer

INSMED Inc

Security class
Common Stock
Shares / value
133,015
Estimated value
$10,496,214
Report date
07 Feb 2025
Price
$78.91
Ownership
Direct
Form 4 holding Chief Commercial Officer

INSMED Inc

Security class
Stock Option (right to buy)
Shares / value
31,930
Estimated value
$654,246
Report date
08 Jan 2025
Price
$20.49
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

IRulya Therapeutics Inc.

Security class
Director Stock Option (Right to Buy)
Shares / value
17,000
Estimated value
Report date
09 Nov 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by John Drayton Wise

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .